Loading the company…
Loading the company…
㈜그린명품제약
English name as filed with DART, Korea’s corporate disclosure system · Correct the English name ›
Last updated 2026-11-02 · Korean page ›
Verification level — how far we have checked
L0 · Public records — NPS workforce · filed financials · patents — public data
A company based in Gyeonggi, founded in 2014. Industry: Wholesale & Retail. Revenue for 2025 was ₩16.9bn. It has 48 employees enrolled in the National Pension Service (as of Aug 2026). It is externally audited; the latest audit opinion is “Unqualified”.
Loading…
Latest filing 2022-05-30 · latest registration 2026-01-23 · newest first
본 발명에 따른 침향수 제조방법은 침향나무를 1.0㎜ ~ 2.0㎜의 크기로 분쇄하는 단계; 상기 분쇄된 침향나무를 식용 알코올에 첨가하여 혼합물을 제조하는 단계; 상기 혼합물에서 상기 침향나무의 유효성분을 기설정된 시간동안 추출하는 단계; 상기 혼합물에 포함된 상기 식용 알코올을 제거하여 침향 추출물을 마련하는 단계; 상기 침향 추출물을 식용 알코올에 용해시킨 후, 정제수와 천연 계면활성제를 첨가 및 교반하여 침향 추출액을 마련하는 단계; 및 상기 침향 추출액에 상기 식용 알코올의 끓는점보다 높은 온도를 갖는 정제 열수를 혼합하여 잔여 식용 알코올을 제거하는 단계;를 포함할 수 있다.
본 발명에 따른 한약재의 로스팅 방법은 한약재를 기설정된 크기로 절단하는 단계; 로스팅 변수인 온도, 시간, 횟수를 달리하여 상기 절단된 한약재를 로스팅(roasting)하는 단계; 상기 로스팅 변수에 따라 로스팅된 각각의 한약재에 대한 유효성분 및 유해성분을 분석하는 단계; 및 분석된 상기 유효성분 및 유해성분의 함량에 따른 최적의 로스팅 변수를 획득하는 단계;를 포함할 수 있다.
KIPO KIPRIS · checked 2026-10-15 · newest filings first · right: registration date (filing date if not yet registered) · 2 of 2 · titles and abstracts are in Korean as filed · click a row for details ▾
For now we hold public records only (National Pension Service · DART filings · patents · registers · press). When the company files material in our IR Room, it moves to L1. We do not score or rate companies — we only state how far we have checked.
| KRW bn | 2024 | 2025 |
|---|---|---|
| Revenue | 18.3 | 16.9 |
| Cost of sales | 15.0 | 13.1 |
| Gross profit (loss) | 3.4 | 3.8 |
| Selling, general and administrative expenses | 3.4 | 3.7 |
| Operating income (loss) | (0.0) | 0.1 |
| Non-operating income | 0.0 | 0.1 |
| Other gains | 0.0 | 0.1 |
| Finance income | 0.0 | 0.0 |
| Non-operating expenses | 0.3 | 0.2 |
| Other losses | 0.0 | — |
| Finance costs | 0.3 | 0.2 |
| Other | 0.0 | — |
| Profit (loss) before tax | (0.3) | (0.0) |
| Income tax expense | 0.0 | 0.0 |
| Net income (loss) | (0.3) | (0.0) |
Revenue ₩16.9bn, down 8.1% YoY.
Operating margin 0.6% (prior -0.0%).
Net income ₩-0bn.
Need more than is shown here? Ask for more information — full review report · valuation · executive teaser · IM · competitor analysis · due diligence. Tell us what you need and we will reply by email with scope, cost and timing.
Is this your company?
If anything here is wrong, tell us — we check it against the original and correct it. You do not need to join. If you would like your financials verified and this page completed, that is a separate process.
Headlines and links to public articles only · not checked by us (original ↗) · articles are in Korean — English headlines are our translation; where none is shown, “Read in English ›” opens a machine translation · “Broker view” is a forecast, not reported results · checked 2026-11-06